Description

Renew Spray (CJC-1295 No DAC + Ipamorelin)

Renew Spray (CJC-1295 No DAC + Ipamorelin) contains 10mg CJC-1295 No DAC and 10mg Ipamorelin, totaling 200mcg per spray and 20mg in total.

Ipamorelin
CAS number	170851-70-4
Molar Mass	711.868 g·mol−1
Chemical Formula	C38H49N9O5
IUPAC Name	(2S)-6-Amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide

Mod grf 1-29/CJC-1295 No Dac
CAS Number	86168-78-7
Molar Mass	3357.93 g·mol−1
Chemical Formula	C149H246N44O42S
IUPAC Name	L-Tyrosyl-L-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide

Introduction

Renew Spray is a research peptide formulation, blending CJC-1295 No DAC and Ipamorelin. Designed exclusively for research purposes, this innovative combination provides researchers with a valuable tool to explore growth-related processes, potential synergies, and therapeutic applications related to growth hormone regulation.

Key Characteristics

CJC-1295 No DAC is recognized for its role in stimulating growth hormone release, CJC-1295 No DAC contributes to the blend’s focus on growth-related research. Ipamorelin is known for its growth hormone-stimulating properties, Ipamorelin complements CJC-1295 No DAC in this research formulation.

Research Applications

Renew Spray is formulated for researchers investigating growth-related processes, exploring potential synergies between CJC-1295 No DAC and Ipamorelin, and studying therapeutic applications related to growth hormone regulation.

Research Benefits

Potential for Synergistic Benefit

Researchers may explore the combined effects of CJC-1295 No DAC and Ipamorelin, assessing potential synergies in growth-related processes.

Ipamorelin and Weight Gain

Studies may delve into Ipamorelin’s impact on weight gain, providing insights into its metabolic effects.

CJC 1295 No DAC and Treatment of Growth Hormone Deficiency

Researchers are encouraged to investigate the potential therapeutic applications of CJC-1295 No DAC in the treatment of growth hormone deficiency.

Summary

Renew Spray (CJC-1295 No DAC + Ipamorelin) is a research peptide formulation designed for scientific exploration into growth-related processes. With a focus on potential synergistic benefits, metabolic effects related to weight gain, and therapeutic applications, this blend provides researchers with a versatile tool for in-depth studies.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144. PMID: 12374906. [Read More].
2. Timms M, Ganio K, Forbes G, Bailey S, Steel R. An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma. Drug Test Anal. 2019 Jun;11(6):804-812. doi: 10.1002/dta.2554. Epub 2018 Dec 25. PMID: 30489688. [Read More].